The Antidiabetic Effect of MSCs is not Impaired by Insulin Prophylaxis and is not Improved by a Second Dose of Cells

Files

The Antidiabetic Effect of MSCs Is Not Impaired by Insulin Prophylaxis and Is Not Improved by a Second Dose of Cells (1).pdf (559.36 KB)

Date

2011

Type:

Artículo

Collections

Artículos Medicina y Ciencias de la Salud

Descargas totales

15

Vistas totales

2
Gestores bibliográficos

Authors

item.contributor.advisor

ORCID:

Journal Title

Journal ISSN

Volume Title

Publisher

item.page.isbn

item.page.issn

item.page.issne

item.page.doiurl

URI

http://hdl.handle.net/11447/874
 http://dx.doi.org/10.1371/journal.pone.0016566

item.page.extent

item.page.accessRights

item.page.other

item.page.references

Abstract

Type 1 diabetes mellitus (T1D) is due to autoimmune destruction of pancreatic beta-cells. Previously, we have shown that intravenously administered bone marrow-derived multipotent mesenchymal stromal ...

Description

item.page.coverage.spatial

item.page.sponsorship

Citation

PLOS ONE, 2011, vol. 6, n° 1, Número de artículo: e16566

Keywords

Mesenchymal stem-cells , Hepatocyte growth-factor , Versus-host-disease , Bone-marrow-cells , Stromal cells , Islet transplantation , Progenitor cells , Diabetic mice , In-vitro , Tissue-repair

item.page.dc.rights

item.page.dc.rights.url

Estadísticas de uso
2 1,5 1 0,5 0
Agosto 2025Septiembre 2025Octubre 2025Noviembre 2025Diciembre 2025Enero 2026Febrero 2026

Implementado por OpenGeek Services